Publications by authors named "Kate L Lowe"

Claim this Profile
L
Lymphatic blood filling in CLEC-2-deficient mouse models.
Elizabeth J Haining, Kate L Lowe, Surasak Wichaiyo, Raghu P Kataru, Zoltan Nagy

Platelets· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.
Charlotte H Coles, Rachel M Mulvaney, Sunir Malla, Andrew Walker, Kathrine J Smith, Kate L Lowe

J Immunol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.
Kate L Lowe, David Cole, Rupert Kenefeck, Ita OKelly, Marco Lepore

Cancer Treat Rev· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.
Jane Harper, Katherine J Adams, Giovanna Bossi, Debbie E Wright, Andrea R Stacey, Kate L Lowe

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine and neurotoxicity in engineered T-cell therapy.
Kate L Lowe, Crystal L Mackall, Elliot Norry, Rafael Amado, Bent K Jakobsen

Gene Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.
Jessica R Hitchcock, Charlotte N Cook, Saeeda Bobat, Ewan A Ross, Adriana Flores-Langarica, Kate L Lowe

J Clin Invest· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state.
Kate L Lowe, Leyre Navarro-Núñez, Cécile Bénézech, Saba Nayar, Bethany L Kingston

Eur J Immunol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.
Kate L Lowe, Brenda A Finney, Carsten Deppermann, René Hägerling, Salomé L Gazit

Blood· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.
Craig E Hughes, Brenda A Finney, Frank Koentgen, Kate L Lowe, Steve P Watson

Blood· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets.
Alessandra Borgognone, Kate L Lowe, Stephen P Watson, Melanie Madhani

Platelets· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet CLEC-2 and podoplanin in cancer metastasis.
Kate L Lowe, Leyre Navarro-Nunez, Stephen P Watson

Thromb Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.
Brenda A Finney, Edina Schweighoffer, Leyre Navarro-Núñez, Cecile Bénézech, Francesca Barone, Kate L Lowe

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis